MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/978-3-031-97242-3_12

Медицинская библиотека · Cancer treatment and research · 2025

Advancing Prostate Cancer Treatment: Innovations and Challenges in Immunotherapy.

Singhal Gargi, Garg Pankaj, Mohanty Atish, Kollimuttathuillam Sudarsan Vishnu, Wheeler Deric, Adesunloye Bamidele A, Singhal Sharad S

СтатьяОбзорПеревод в очереди

Аннотация

Prostate cancer (PCa), a leading cause of cancer mortality in men, has experienced a paradigm shift with the rise of immunotherapy. This chapter examines the immunological landscape of PCa and highlights key immunotherapeutic approaches, including cancer vaccines, immune checkpoint inhibitors (ICIs), adoptive cell therapies, and cytokine-based treatments. Emerging innovations, such as oncolytic viruses, neoantigen-based therapies, and bispecific antibodies, are also examined. Challenges like the immunosuppressive tumor microenvironment (TME), limited predictive biomarkers, and immune-related adverse events (irAEs) are addressed, alongside promising combination strategies with androgen deprivation therapy (ADT), radiotherapy, and targeted therapies. Advances in biomarker discovery and artificial intelligence (AI) are emphasized for their role in optimizing personalized immunotherapy. This chapter underscores the need for equitable access to these advancements and concludes with a vision for integrating immunotherapy into standard care, offering durable and transformative outcomes for PCa patients.

Для цитирования: Singhal Gargi, Garg Pankaj, Mohanty Atish, Kollimuttathuillam Sudarsan Vishnu, Wheeler Deric, Adesunloye Bamidele A, Singhal Sharad S. Advancing Prostate Cancer Treatment: Innovations and Challenges in Immunotherapy.. Cancer treatment and research. 2025. DOI: 10.1007/978-3-031-97242-3_12.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.